ALG-010133
- Generic Name
- ALG-010133
A Study of ALG-010133 Drug to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Single and Multiple Doses in Healthy Volunteers and CHB Subjects
- First Posted Date
- 2020-07-24
- Last Posted Date
- 2022-03-15
- Lead Sponsor
- Aligos Therapeutics
- Target Recruit Count
- 103
- Registration Number
- NCT04485663
- Locations
- 🇨🇳
Nanfang Hospital of Southern Medical University, Guangzhou, Guangdong, China
🇨🇳The First Hospital of Jilin University, Changchun, Jilin, China
🇰🇷Pusan National University Hospital, Busan, Korea, Republic of
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath